Floatz logo

Tadalafil

Erectile Dysfunction

Surgical Outcomes Research Centre (SOuRCe)Small moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
81/ 100

Competitive context

19 Active assets in the Erectile Dysfunction cohort.

Asset / SponsorPhaseRating
Sildenafil
The Netherlands Cancer Institute
Phase 4BB
Ningmitai
Xintian Pharmaceutical
Phase 4BB
BAY38-9456
Bayer
Phase 4BB
Indocyanine Green
Ankara University
Phase 4BB
Vardenafil
Medical University of Vienna
Phase 4BB

View all 38 →

Same molecule, other indications

Tadalafil is also rated in:

sexual disorderDormant
BBB
Indicative ·
72 / 100
View asset →
Duchenne muscular dystrophyDormant
BB
Indicative ·
65 / 100
View asset →
diastolic heart failureDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →